Skip to main content
. 2021 Feb 12;5:9. doi: 10.1038/s41698-021-00145-8

Fig. 2. Schematic of somatic molecular aberrations.

Fig. 2

WGS and transcriptomic sequencing demonstrated multiple aberrations in the MAPK pathway, supporting downstream targeting with a MEK inhibitor (MEKi).